/Investor DB

ACF Investors — 2017 Investments

2 investments dated 2017 · listed companies and verified rows first · show all

Neurovalensneurovalens.comin𝕏Seed · Jul 2017 · $1M

Neurovalens develops medical devices using neuromodulation technology to address health conditions including obesity and anxiety disorders.

BiotechDeep TechHealthtechMedical DevicesMental HealthNorthern Ireland, GB

Dr. Jason McKeown(MD PhD, Founder)

Co-investorsClarendon Fund Managers Ltd.IQ CapitalStartXBeltrae PartnersBritish Business BankInnovation Ulster+2 more

Vantage Powervantage-power.cominMar 2017acquired by Allison Transmission

Vantage Power develops electrification and connectivity technologies for commercial and defense vehicles, including hybrid-retrofit systems for city buses, liquid-cooled lithium-ion battery packs, and the VPVision data connectivity and analytics platform.

CleantechHardwareIoTMobility & Transportation

Alexander Schey(Co-founder)inToby Schulz(Co-founder)in

Co-investorsMartlet CapitalOrigin Capital

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.